icon
icon
icon
icon
Upgrade
icon

Kanghua Biological's HK IPO prospectus has expired, with the richest portfolio of HPV vaccines globally

AInvestTuesday, Jul 30, 2024 11:00 pm ET
1min read

The prospectus of Beijing Kanglife Bioscience Co., Ltd. (Kanglife, Northbound Stock Code: 833575.BJ) filed on January 29, 2024, has been expired for six months, and will expire on July 29, 2024. The joint sponsors of the prospectus are CITIC Securities and BOC International.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.